Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan

Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan

Background: Group B Streptococcus (GBS) is a leading pathogen causing life-threatening bacterial infections in neonates (early- or late-onset) and infants, and is associated with preterm and stillbirth. Japan introduced national guidelines to reduce early-onset neonatal GBS disease, with universal p...

Full description

Bibliographic Details
Main Authors: Sumire Sorano, Simon R Procter, Anna C Seale
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Vaccine: X
Subjects:
Group B streptococcus (GBS)
Vaccine
Maternal immunization
Cost-effectiveness analysis
Neonatal sepsis
Neonatal meningitis
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136223000736

Internet

http://www.sciencedirect.com/science/article/pii/S2590136223000736

Similar Items